Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Bunn · SciRah

Researcher profile · Semantic Scholar

P. Bunn

Share profile

P. Bunn — researcher profile on SciRah

h-index: 100
Works: 604
Citations: 40K

Most-cited papers

Small-cell lung cancer: what we know, what we need to know and the path forward
A. Gazdar, P. Bunn, J. Minna
2017Nature Reviews. Cancer811 citations
Semantic Scholar
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Z. Megyesfalvi, C. Gay, H. Popper, R. Pirker +13 more
2023Ca442 citations Open access
Semantic Scholar
IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY
W. Travis, S. Dacic, I. Wistuba, L. Sholl +39 more
2020Journal of Thoracic Oncology432 citations Open access
Semantic Scholar
New and emerging targeted treatments in advanced non-small-cell lung cancer.
F. Hirsch, K. Suda, J. Wiens, P. Bunn
2016The Lancet413 citations
Semantic Scholar
Scientific Advances in Lung Cancer 2015
A. Tsao, G. Scagliotti, P. Bunn, D. Carbone +33 more
2016Journal of Thoracic Oncology246 citations Open access
Semantic Scholar
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
J. Chaft, F. Oezkan, M. Kris, P. Bunn +32 more
2022Nature Medicine233 citations Open access
Semantic Scholar
Characteristics and Outcomes of Patients With Metastatic KRAS‐Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
B. El Osta, M. Behera, Sungjin Kim, L. Berry +11 more
2019Journal of Thoracic Oncology209 citations Open access
Semantic Scholar
HER2 Mutations in Lung Adenocarcinomas: A Report from the Lung Cancer Mutation Consortium
R. Pillai, M. Behera, L. Berry, M. Rossi +5 more
2017Cancer196 citations Open access
Semantic Scholar
The incidence of brain metastases in stage IV ROS1-rearranged non-small cell lung cancer and rate of central nervous system progression on crizotinib.
T. Patil, Derek E. Smith, P. Bunn, D. Aisner +6 more
2018Journal of Thoracic Oncology193 citations Open access
Semantic Scholar
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.
D. Tan, S. Yom, M. Tsao, H. Pass +17 more
2016Journal of Thoracic Oncology191 citations Open access
Semantic Scholar
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.
M. Socinski, C. Obasaju, D. Gandara, F. Hirsch +14 more
2017Journal of Thoracic Oncology184 citations Open access
Semantic Scholar
The Impact of Smoking and TP53 mutations in lung adenocarcinoma patients with targetable mutations – the Lung Cancer Mutation Consortium (LCMC2)
D. Aisner, L. Sholl, L. Berry, M. Rossi +23 more
2017Clinical Cancer Research175 citations Open access
Semantic Scholar
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
G. Blumenthal, P. Bunn, J. Chaft, C. McCoach +39 more
2018Journal of Thoracic Oncology164 citations Open access
Semantic Scholar
Clinicopathologic Features of Advanced Squamous NSCLC.
M. Socinski, C. Obasaju, D. Gandara, F. Hirsch +16 more
2016Journal of Thoracic Oncology158 citations Open access
Semantic Scholar
MET IHC is a Poor Screen for MET Amplification or MET exon 14 mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium
R. Guo, L. Berry, D. Aisner, Jamie E. Sheren +7 more
2019Journal of Thoracic Oncology157 citations Open access
Semantic Scholar
Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3).
D. Kwiatkowski, V. Rusch, J. Chaft, B. Johnson +16 more
2019Journal of Clinical Oncology141 citations
Semantic Scholar
MOLECULARLY TARGETED THERAPIES IN NON-SMALL CELL LUNG CANCER ANNUAL UPDATE 2014
D. Morgensztern, Meghan J. Campo, S. Dahlberg, R. Doebele +20 more
2015Journal of Thoracic Oncology137 citations Open access
Semantic Scholar
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non–Small Cell Lung Cancer
J. Pacheco, D. Gao, Derek E. Smith, T. Purcell +11 more
2018Journal of Thoracic Oncology132 citations Open access
Semantic Scholar
Barasertib (AZD1152), a small molecule Aurora B inhibitor, inhibits the growth of SCLC cell lines in vitro and in vivo
B. Helfrich, Jihye Kim, D. Gao, D. Chan +3 more
2016Molecular Cancer Therapeutics89 citations Open access
Semantic Scholar
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
David Dora, C. Rivard, Hui Yu, P. Bunn +10 more
2020Molecular Oncology83 citations Open access
Semantic Scholar
PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
Ju-Whei Lee, J. Chaft, A. Nicholas, A. Patterson +26 more
202171 citations Open access
Semantic Scholar
Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment
C. Langer, C. Obasaju, P. Bunn, P. Bonomi +15 more
2016Journal of Thoracic Oncology62 citations Open access
Semantic Scholar
The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer
N. Navani, D. Fisher, J. F. Tierney, R. Stephens +25 more
2018Chest53 citations Open access
Semantic Scholar
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition
H. Scarborough, B. Helfrich, Matias Casás-Selves, A. Schuller +8 more
2016Clinical Cancer Research52 citations Open access
Semantic Scholar
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation
C. Rolfo, N. Meshulami, A. Russo, F. Krammer +15 more
2021Journal of Thoracic Oncology41 citations Open access
Semantic Scholar
OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study
D. Carbone, Ju-Whei Lee, M. Kris, I. Wistuba +27 more
202139 citations Open access
Semantic Scholar
KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer
Ya-Yi He, P. Bunn, Cai-Cun Zhou, D. Chan
2016OncoTarget35 citations Open access
Semantic Scholar
Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.
J. Pacheco, P. Bunn
2019Clinical Lung Cancer33 citations
Semantic Scholar
The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC
Ya-Yi He, Sang-Tian Liu, J. Mattei, P. Bunn +2 more
2018Drug Design, Development and Therapy31 citations Open access
Semantic Scholar
Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench
K. Suda, P. Bunn, C. Rivard, T. Mitsudomi +1 more
2016Journal of Thoracic Oncology31 citations Open access
Semantic Scholar
Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer
V. Rusch, A. Nicholas, G. Patterson, Salama N. Waqar +25 more
2022Journal of Thoracic and Cardiovascular Surgery30 citations Open access
Semantic Scholar
Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer
S. Leonard, Helen Lee, Daniel F. Gaddy, S. Klinz +7 more
2017Anti-Cancer Drugs30 citations Open access
Semantic Scholar
2020 Innovation Based Optimism for Lung Cancer Outcomes.
E. Schenk, T. Patil, J. Pacheco, P. Bunn
2020The Oncologist29 citations Open access
Semantic Scholar
A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High Risk Current and Former Smokers
R. Keith, P. Blatchford, D. Merrick, P. Bunn +5 more
2019Cancer Prevention Research28 citations Open access
Semantic Scholar
Altered cell-cycle control, inflammation and adhesion in high-risk persistent bronchial dysplasia
D. Merrick, M. Edwards, W. Franklin, M. Sugita +23 more
2018Cancer Research28 citations Open access
Semantic Scholar
Brief Report: Baseline and on treatment characteristics of serum tumor markers in stage IV oncogene-addicted adenocarcinoma of the lung
S. Noonan, T. Patil, D. Gao, Gentry G. King +7 more
2017Journal of Thoracic Oncology27 citations Open access
Semantic Scholar
Long‐term safety and survival with gefitinib in select patients with advanced non–small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP)
F. Hirsch, L. Sequist, I. Gore, M. Mooradian +8 more
2018Cancer24 citations Open access
Semantic Scholar
Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience.
D. Aisner, L. Sholl, L. Berry, E. Haura +16 more
201622 citations
Semantic Scholar
Molecular and Immune Biomarker Testing in Squamous‐Cell Lung Cancer: Effect of Current and Future Therapies and Technologies
F. Hirsch, K. Kerr, P. Bunn, Edward S. Kim +20 more
2018Clinical Lung Cancer21 citations Open access
Semantic Scholar
Characteristics and outcomes of patients (pts) with metastatic KRAS mutant lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC) database.
B. El Osta, M. Behera, Sungjin Kim, L. Berry +9 more
201719 citations
Semantic Scholar
Karnofsky Award 2016: A Lung Cancer Journey, 1973 to 2016.
P. Bunn
2017Journal of Clinical Oncology19 citations
Semantic Scholar
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
P. Mack, J. Gomez, A. M. Rodilla, J. Carreño +26 more
2022Cancer Cell16 citations Open access
Semantic Scholar
Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer
Shidan Wang, Ruichen Rong, Dong-Han M. Yang, J. Fujimoto +16 more
2023Journal of Clinical Investigation15 citations Open access
Semantic Scholar
LCMC LEADER neoadjuvant screening trial: LCMC4 evaluation of actionable drivers in early-stage lung cancers.
B. Sepesi, David R. Jones, B. Meyers, J. Chaft +14 more
2022Journal of Clinical Oncology15 citations
Semantic Scholar
Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury
Shawn J. Rice, Victoria Hyland, M. Behera, S. Ramalingam +2 more
2020Journal of Thoracic Oncology14 citations Open access
Semantic Scholar
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.
Jacob Langston, T. Patil, D. Camidge, P. Bunn +6 more
2023Lung Cancer13 citations
Semantic Scholar
MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3)
V. Rusch, J. Chaft, B. Johnson, I. Wistuba +16 more
2018Journal of Thoracic Oncology13 citations Open access
Semantic Scholar
New Developments in Neoadjuvant Therapy for Lung Cancer.
P. Bunn, E. Schenk, J. Pacheco, A. Dimou
2019Oncology11 citations
Semantic Scholar
Systemic Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancers.
P. Bunn, A. Dimou
2018Journal of Clinical Oncology11 citations
Semantic Scholar
Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance
T. Boyle, F. Khalil, M. Mino-Kenudson, G. Sica +18 more
2019Applied immunohistochemistry & molecular morphology (Print)10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Hirsch×16
Invite
F. Hirsch — researcher profile on SciRah
M. Kris×16
Invite
M. Kris — researcher profile on SciRah
I. Wistuba×14
Invite
I. Wistuba — researcher profile on SciRah
D. Kwiatkowski×14
Invite
D. Kwiatkowski — researcher profile on SciRah

×12

Invite

S. Ramalingam — researcher profile on SciRah

Invite

B. Johnson — researcher profile on SciRah

Invite

D. Carbone — researcher profile on SciRah

Invite

J. Chaft — researcher profile on SciRah

Invite

E. Haura — researcher profile on SciRah

Invite

L. Berry — researcher profile on SciRah

Invite

L. Sholl — researcher profile on SciRah

Invite

V. Rusch — researcher profile on SciRah